Literature DB >> 19326959

Standardizing quality assessment of observational studies for decision making in health care.

Diana I Brixner1, Anke-Peggy Holtorf, Peter J Neumann, Daniel C Malone, John B Watkins.   

Abstract

Mesh:

Year:  2009        PMID: 19326959     DOI: 10.18553/jmcp.2009.15.3.275

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


× No keyword cloud information.
  3 in total

1.  Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets.

Authors:  Anke-Peggy Holtorf; Diana Brixner; Brandon Bellows; Abdulkadir Keskinaslan; Joseph Dye; Gary Oderda
Journal:  Am Health Drug Benefits       Date:  2012-11

2.  A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.

Authors:  Marc L Berger; Bradley C Martin; Don Husereau; Karen Worley; J Daniel Allen; Winnie Yang; Nicole C Quon; C Daniel Mullins; Kristijan H Kahler; William Crown
Journal:  Value Health       Date:  2014-03       Impact factor: 5.725

3.  Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.

Authors:  Marc L Berger; Harold Sox; Richard J Willke; Diana L Brixner; Hans-Georg Eichler; Wim Goettsch; David Madigan; Amr Makady; Sebastian Schneeweiss; Rosanna Tarricone; Shirley V Wang; John Watkins; C Daniel Mullins
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-09       Impact factor: 2.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.